Rachel McMinn

CIK: 0001606302

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NGNE

Neurogene Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

NGNE
Neurogene Inc.
Sep 22, 2026
Exercise(M)
Direct
756 shares at avg. $25.32$19K
NGNE
Neurogene Inc.
Mar 26, 2026
Sale(S)
Direct
3.4K shares at avg. $22.07$74K
NGNE
Neurogene Inc.
Feb 20, 2026
Award(A)
Direct
25.9K shares-
NGNE
Neurogene Inc.
Mar 26, 2025
Award(A)
Direct
23.9K shares-
NGNE
Neurogene Inc.
Nov 22, 2024
Purchase(P)
Direct
47.5K shares at avg. $20.40$969K

		Type	Shares	Price		Ownership
Sep 22, 2026	NGNE Neurogene Inc.	Exercise(M)	756	$25.32	$19,142	Direct
Mar 26, 2026	NGNE Neurogene Inc.	Sale(S)	3,352	$22.07	$73,995	Direct
Feb 20, 2026	NGNE Neurogene Inc.	Award(A)	25,900	-	$0	Direct
Mar 26, 2025	NGNE Neurogene Inc.	Award(A)	23,900	-	-	Direct
Nov 22, 2024	NGNE Neurogene Inc.	Purchase(P)	47,500	$20.40	$969,000	Direct

1-5 of 5 transactions

About McMinn Rachel

McMinn Rachel (SEC CIK 0001606302) files insider reports with the SEC as Chief Executive Officer of Neurogene Inc. (NGNE).

Signal8 holds 5 ownership filings by McMinn Rachel, all Form 4s, filed between Nov 25, 2024 and Oct 2, 2026. Those filings report 5 transactions, from Nov 22, 2024 to Sep 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McMinn Rachel's filings is in NEW YORK, NY.

Recent filings by McMinn Rachel

Sep 22, 2026: Option exercise of NGNE shares (Form 4, code M).
Mar 26, 2026: Open-market sale of NGNE shares (Form 4, code S).
Feb 20, 2026: Grant or award of NGNE shares (Form 4, code A).
Mar 26, 2025: Grant or award of NGNE shares (Form 4, code A).
Nov 22, 2024: Open-market purchase of NGNE shares (Form 4, code P).

Other insiders filing for Neurogene Inc. (NGNE)

Cvijic Christine Mikail, President and CFO
Woods Keith, Director
Shafer Christina, Chief Commercial Officer
Jordan Julie, Chief Medical Officer
Cobb Stuart, Chief Scientific Officer
PALEKAR ROHAN, Director

How to read Form 4 transaction codes